Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Review
DOI: 10.54448/ijn22101
Submitted: 12-23-2021
Published: 12-23-2021

An ethical review on the search for performance: evidence-based nutrology and the use without indication of anabolic steroids

Confiance Medical Clinic, Brasília, Distrito Federal, Brazil
FAMINAS - Faculty of Minas, medical course, Minas Gerais, Brazil
Testosterone Hormone Hypogonadism

Abstract

This study aimed to evaluate what is new in the controversial use of testosterone, as an indication in pathologies such as hypogonadism or its use by athletes and bodybuilders in search of performance. Much is said about the subject and many myths were created without any scientific foundation, one of the objectives of the monograph is to show that when there is a precise clinical indication, testosterone is necessary and extremely beneficial to the patient. It was evaluated in current literature through books and articles, advances in physiology, regulation, treatment of late adult hypogonadism, incidence of use and the most common analogues used by athletes, the harms and benefits expected from the use of the hormone and especially what we have again on cardiovascular safety in testosterone use. After an extensive review, it is still not possible to affirm all the benefits and harms of using the hormone, many old studies are disputed in new studies and even presented results opposite to what was previously believed.

Metrics

Metrics Loading ...

References

  1. Mustafa EM, Filho IJZ, Ferreira VRR, Sabino SB, Sternieri GB, Verdi LB, Queiroz COV, Sbardellini BC, Braile-Sternieri MCVB. AMI and Anabolic-Androgenic Steroids: Case Report with Systematic Review. Curr Cardiol Rev. 2021;17(5):e190721189769. doi: 10.2174/1573403X16999201231203405. PMID: 33390145.
  2. Lise MLZ, Gama ESTS, Ferigolo M, Barros HMT. O abuso de esteróides anabólico-androgênicos em atletismo Rev Ass Med Brasil 1999; 45(4): 364-70.
  3. Silva PRP, Machado J, Leonel C, Figueiredo VC, Cioffi AP, Prestes MC, Czepielewski MA. Prevalência do uso de agentes anabólicos em praticantes de musculação de Porto Alegre Rev Ass Med Brasil 1999; 45(4): 364-70.
  4. Araújo JP. O uso de esteroides androgênicos anabolizantes entre estudantes do ensino médio no Distrito Federal dissertação a título de mestre em Educação física pela Universidade Católica de Brasília, 2003.
  5. Peralta J, Amancio OMS. A creatina como suplemento ergogênico para atletas Rev. Nutr., Campinas, 2002, 15(1):83-93.
  6. Bhasin, Shalender; Storer, Thomas W.; BERMAN, Nancy Berman; Callegari Carlos; Clevenger Brenda; Phillips Jeffrey; BunnellThomas J.; Tricker, Ray; Shirazi, Aida; Casaburi, Richard The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men The New England Journal of Medicine, 1996, 4, 335:1.
  7. Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR. Modern Nutrition in Health and Disease (Modern Nutrition in Health & Disease (Shils). 11ª ed. Lippincott Williams & Wilkins, 2014.(Traduzido para Português).
  8. Ribas Filho D, Suen VMM – Tratado de Nutrologia. Manole, 2013.
  9. Judelson DA, Maresh CM, Anderson JM et al. Sports Med 2007;37:907-21.
  10. B Chock TC, Lin CS, Li AS. Plasma testosterone is associated with framingham risk score. Aging Male 012 Sep;15(3):134-9. doi: 10.3109/13685538.2011.654369. Epub 2012 Feb 27.
  11. Becher, Edgardo; Torres Luiz Otavio; Glina Sidney Consenso Latino-Americano sobre DAEM São Paulo : PlanMark, 2013.
  12. Cussons AJ, Bhagat CI, Fletcher SJ, Walsh JP. Brown-Séquard revisited: a lesson from history on the placebo effect of androgen treatment. Med J Aust. 2002 Dec 2-16;177(11-12):678-9. doi: 10.5694/j.1326-5377.2002.tb05014.x. PMID: 12463999.
  13. G Corona, G Tastrelli, M Monami A, Guay J, Buvat A, Sforza G, Forti E Mannucci, M Maggi. Hypogonadism as a risk factor for a cardiovascular mortality in men: A met-analytic study. Eur J Endocrinol. 2011 Nov;165(5):687-701. doi: 10.1530/EJE-11-0447. Epub 2011 Aug 18.
  14. Gardner DG. Endocrinologia Básica e Clinica de Greenspan 9º Edição: Mcgraw Hill, 2012.
  15. Gebara OCE, Vieira NW, Meyer JW, Calich ALGT, Eun J, Pierri H, Wajngarten M, Aldrighi JM. Efeitos Cardiovasculares da testosterona, Arq Bras Cardiol, volume 79 (nº 6), 644-9, 2002.
  16. Rosano GMCF, Leonardo PP et al. Acute anti-isquemic effect of testosterone in men with coronary artery disease. Circulation 1999; 99: 1666-70.
  17. Hong Y, LI Hongzhi Y, Yate-Ching, Chen S. Molecular characterization of aromatase, Ann N Y Acad Sci. 2009 February ; 1155: 112–120. doi:10.1111/j.1749-6632.2009.
  18. J Shapiro J, Christiana WHF. Testosterone and other anabolic steroidsas cardiovascular drugs. Am J Ther 1999; 6: 167-74. E Yang XC, Jing TY, Resnick LM, Phillips GB. Relation of hemostatic risk factors for coronary heart disease and to sex hormones in men. Arterioscler Thromb 1993; 13: 467-71.
  19. JF Knudsen, SR Max. Aromatization of androgens to estrogens mediates increased activity of glucose 6-phosphate dehydrogenase in rat levator ani muscle. Endocrinol. 1980, 106(2):440-43.
  20. JS Brand, L Van der Tweel, DE Grobbee, MH Emmelot-VonK YT, Van Der Schouw. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of obervational studies. Int J Epidemiol 2011;40(189)207-23.
  21. Llewellyn, William. Anabolics. 9th edition: Molecular Nutrition, 2009.
  22. M, Zitzmann, S Faber, E Nieschlag. Association of specific symptoms and metabolic risks with serum testosterone in olfer men. J Clin Endorinolol Metab, 2006, 91;4335-4343.
  23. Machado VG, N Faruk. Compostos fosfatados ricos em energia. Química Nova, 22(3), 1999.
  24. Means GD, Mahendroo MS, Corbin CJ, Mathis JM, Powell FE, Mendelson CR, Simpson ER. Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem. 1989 Nov 15;264(32):19385-91. PMID: 2808431.
  25. Noirhomme P, Jacquet L, Underwood M, EL Khoury G, Goenen M, Dion R. The effect of chronic mechanical circulatory support on neuroendocrine activation inpatients with end-stage heart failure. Eur J Cardio thoracic Surg 1999; 16: 63-7
  26. S Lu, NG Simon Y, Wang SH. Neural androgen receptor regulation: effects of androgen andantiandrogen J Neurobiol 1999 Dec;41:505-12.
  27. Srougi M, Ribeiro LA, Piovesan AC, Colombo JR, Nesrallah A. Doenças da próstata. Rev Med, São Paulo, 2008 jul.-set.;87(3):166-77.
  28. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N. Transdermal Testosterone Gel Improves Sexual Function, Mood, Muscle Strength, and Body Composition Parameters in Hypogonadal Men The Journal of Clinical Endocrinology & Metabolism Printed, Vol. 85, No. 8, U.S.A, 2000.

How to Cite

Silveira Neto, L. L. da, & Santos, L. R. de S. M. (2021). An ethical review on the search for performance: evidence-based nutrology and the use without indication of anabolic steroids. International Journal of Nutrology, 15(1). https://doi.org/10.54448/ijn22101